AI ENERGY ENG (01751): The allotment was approximately 0.9% oversubscribed.

18:02 13/05/2026

Zhi Suan Neng Jian (01751) announced that on May 11, 2026 (Monday) at 4:00 pm (the final admission deadline), they received 1 valid application and acceptance made in accordance with the provisional allotment letter, subscribing a total of 889,800 shares of the new shares, accounting for approximately 0.9% of the new shares available for subscription under the rights issue.

AI Energy Engineering (01751) announced that at 4:00 pm on May 11, 2026 (Monday), it received one valid application based on the provisional allotment letter and accepted a total of 889,800 shares of rights shares, accounting for approximately 0.9% of the rights shares available for subscription. Therefore, there is a shortfall of 95,878,200 shares of rights shares, accounting for approximately 99.1% of the total rights shares available for subscription. These shares will be subject to compensation arrangements.

MICROPORT NEURO (02172) spent 986,500 Hong Kong dollars to repurchase 100,000 shares on May 13th.

7ROAD (00797) repurchased 20,000 shares for HK$11,400 on May 13th.

InnoCare Pharma (09969): The Phase I clinical trial of ICP-054 (ZB021) has completed the enrollment of the first subject.

MICROPORT NEURO (02172) spent 986,500 Hong Kong dollars to repurchase 100,000 shares on May 13th.

7ROAD (00797) repurchased 20,000 shares for HK$11,400 on May 13th.

InnoCare Pharma (09969): The Phase I clinical trial of ICP-054 (ZB021) has completed the enrollment of the first subject.